Trophoblastic Neoplasms
Trophoblastic growth, which may be gestational or nongestational in origin. Trophoblastic neoplasia resulting from pregnancy is often described as gestational trophoblastic disease to distinguish it from germ cell tumors which frequently show trophoblastic elements, and from the trophoblastic differentiation which sometimes occurs in a wide variety of epithelial cancers. Gestational trophoblastic growth has several forms, including HYDATIDIFORM MOLE and CHORIOCARCINOMA. (From Holland et al., Cancer Medicine, 3d ed, p1691)
Subtype terms (2)
More specific conditions that are subtypes of Trophoblastic Neoplasms in the MeSH hierarchy.
- Choriocarcinoma
29 drugs (25 approved, 4 experimental)
- Gestational Trophoblastic Disease
41 drugs (33 approved, 8 experimental)
Drugs by status
Phase 2 trials (2)
Organizations
Organization Involved with Phase 3 Indications (12)
- National Cancer Institute (NCI)
- Huazhong University of Science and Technology
- Eastern Cooperative Oncology Group
- Gynecologic Oncology Group
- Mansoura University
- NRG Oncology
- Oregon Health and Science University
- Sichuan University
- University of California, San Diego
- Zhejiang University
- Shandong University
- Zhongshan Medical University
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (2)
Organization Involved with Other Experimental Indications (4)